Biosensors Market is projected to witness a CAGR of 9.5% from 2023 to 2033

According to Future Market Insights’ newly released Biosensors Market analysis report, the global market size of the Biosensors Market in 2022 was held at US$ 24.5 Billion. The predicted market growth is expected to be much larger than the historical trend, with a CAGR of 9.5% from 2023 to 2033. Medical biosensors are likely to be the most profitable market, with a CAGR of more than 10.5% from 2023 to 2033.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16430

The biosensors market is being driven by an increase in chronic illnesses such as diabetes, an increase in biotechnology research and development, and an increase in demand for homecare equipment. The increased use of biosensors in glucose monitoring systems has resulted in market expansion. However, market growth is expected to be hampered by the high costs associated with these devices, as well as a lack of willingness to embrace new treatment devices. Improvements in biosensor technology, on the other hand, that add portability, are expected to drive market growth.

Nanotechnology-based biosensors are expected to be profitable in a variety of industries, including food analysis, imaging operations, and microbial activity monitoring. The market is consolidating as a result of the increasing popularity of medical equipment and customised drugs, as well as a greater demand for non-invasive biosensors and increased research collaboration and agreements among various producers.

Because of their ability to assess fitness as well as the onset and progression of illness, biosensors are widely used in home-based healthcare by patients. As a result, the market is expected to expand throughout the forecast period. A variety of non-medical activities, as well as technological advancement, are expected to broaden its applicability and, as a result, support its growth. Pregnancy testing, cholesterol testing, blood glucose testing, and drug detection are some of the healthcare services that are expected to have a positive market impact.

Government projects aimed at improving proteomics and genomics are expected to drive the biosensors market during the forecast period.

Avail Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16430

Competitive Analysis

Because of the increased demand for biosensors, global manufacturers are accelerating and improving their manufacturing processes by implementing cost-effective solutions. A few of the key players in the biosensors market include Bio-Rad Laboratories Inc., Medtronic, Abbott Laboratories, Biosensors International Group, Ltd., Pinnacle Technologies Inc., Ercon, Inc., DuPont Biosensor Materials, Johnson & Johnson, Koninklijke Philips N.V., LifeScan, Inc., QTL Biodetection LLC, Molecular Devices Corp., Nova Biomedical, Molex LLC, TDK Corporation, Zimmer & Peacock AS, and Siemens Healthcare.

Some of the recent developments of key Biosensors providers are as follows:

  • In January 2022, Roche and Sysmex agreed to a Global Business Partnership (GBP) to provide haematological diagnostic services. The new collaboration will use IT technology to improve clinical decision-making and the consumer experience. This long-running, fruitful collaboration is still going strong, providing haematological diagnostic improvements to labs worldwide.
  • In December 2020, Abbott announced that FreeStyle Libre 2, its next-generation sensor-based glucose monitoring device, has been approved by Health Canada for adults and children (4 years and older) with diabetes.

More Valuable Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Biosensors Market, presenting historical market data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.

Customization Available@ https://www.futuremarketinsights.com/customization-available/rep-gb-16430

Market Segments Covered in Biosensors Market Analysis

By Product Type:

  • Medical
    • Cholesterol
    • Blood Glucose
    • Blood Gas Analyzer
    • Pregnancy Testing
    • Drug Discovery
    • Infectious Disease
  • Food Toxicity
  • Bioreactor
  • Agriculture
  • Environment
  • Others

By Technology:

  • Thermal
  • Electrochemical
  • Piezoelectric
  • Optical

By End-Use:

  • Home Healthcare Diagnostics
  • PoC Testing
  • Food Industry
  • Research Laboratories
  • Security & Biodefense

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

 

About the Author

Ronak Shah

Associate Vice President at Future Market Insights is deeply committed to uncovering actionable insights for consumer and food and beverage players. She brings a unique blend of analysis, industry trends, and consumer behavior to put data into perspective.

What she makes out of data becomes a delight to read. She has authored many opinions, including for publications like Process Industry Informer and Spinal Surgery News, as she understands the market pulse and consumers' shifting preferences.

She likes to bring experts to a roundtable to weigh the impact of a trend on an industry. Catch up with her discussion on the impact of AI in packaging.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these